✦ LIBER ✦

A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children

✍ Scribed by J. Donadieu; P. Boutard; E. Bernatowska; G. Tchernia; G. Couillaud; N. Philippe; E. Le Gall; for the Lenograstim study group

Publisher: Springer
Year: 1997
Tongue: English
Weight: 223 KB
Volume: 156
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s004310050692

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot study of recombinant human granulo

Pilot study of recombinant human granulocyte-macrophage colony–stimulating factor in the treatment of chronic hepatitis B

✍ Julio Martin; Orencio Bosch; Gloria Moraleda; Javier Bartolome; Juan Antonio Qui 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

is a fellow of Ministerio de Educaci6n y Ciencia. J. Bartolome and J.A. Quiroga are recipients of research grants from Fundacion para el Estudio de las Hepatitis Vudes.

Phase II study of cisplatin as a 5-day c

Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer

✍ Yoshikuni Saito; Kiyoshi Mori; Keigo Tominaga; Kouhei Yokoi; Naoto Miyazawa 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 500 KB

Phase I / II trial of human recombinant

Phase I / II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer

✍ G. T. Budd; J. Atiba; R. T. Silver; G. Palmer; S. Armstrong; K. Otto; C. Presant 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 96 KB

A phase I clinical and pharmacologic stu

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

Phase II study of intensive chemotherapy

Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer

✍ Giorgio Vittorio Scagliotti; Umberto Ricardi; Lucio Crinó; Ernesto Maranzano; Fi 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 375 KB

A phase-I trial of the epidermal growth

A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors

✍ Matthew G. Fury; Allan Lipton; Katherine M. Smith; Corinne B. Winston; David G. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 377 KB